{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:57:02Z","timestamp":1786993022348,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jneuroim.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T20:40:44Z","timestamp":1471034444000},"page":"59-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Immune-mediated rippling muscle disease and myasthenia gravis"],"prefix":"10.1016","volume":"299","author":[{"given":"Mariela","family":"Bettini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hernan","family":"Gonorazky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Fulgenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Figueredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Cristiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico S.","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Rugiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.08.011_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/archneur.1996.00550020113023","article-title":"Rippling muscles and myasthenia gravis with rippling muscles","volume":"53","author":"Ansevin","year":"1996","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0010","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1212\/WNL.54.6.1373","article-title":"Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia","volume":"54","author":"Carbone","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jnnp.2009.172742","article-title":"Acquired rippling muscle disease in association with myasthenia gravis","volume":"81","author":"George","year":"2010","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/mus.21446","volume":"41","author":"Jacobi","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2010.11.015","article-title":"Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies","volume":"21","author":"Lo","year":"2011","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0960-8966(99)00065-6","article-title":"Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis","volume":"9","author":"M\u00fcller-Felber","year":"1999","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0035","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nmd.2009.01.002","article-title":"Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two","volume":"19","author":"Schoser","year":"2009","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/1097-4598(200103)24:3<340::AID-MUS1003>3.0.CO;2-X","article-title":"Rippling muscle disease: evidence for phenotypic and genetic heterogeneity","volume":"24","author":"So","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0045","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1002\/mus.10156","article-title":"Rippling muscle disease: a review","volume":"11","author":"Torberg","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0050","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s00415-009-5082-x","article-title":"Acquired rippling muscle disease associated with mild myasthenia gravis: a case report","volume":"256","author":"van Schaik","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0055","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mus.10266","article-title":"Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability","volume":"26","author":"Vernino","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0065","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.57.12.2273","article-title":"A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation","volume":"57","author":"Vorgerd","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1006\/bbrc.1999.1534","article-title":"Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels","volume":"264","author":"Walker","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2016.08.011_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcb.20857","article-title":"Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients","volume":"99","author":"Watkins","year":"2006","journal-title":"J. Cell. Biochem."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281630193X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281630193X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:28:09Z","timestamp":1759048089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557281630193X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":14,"alternative-id":["S016557281630193X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.011","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-mediated rippling muscle disease and myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}